Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 158

1.
2.

The pharmacological actions of polymethylene bistrimethylammonium salts. 1949.

Paton WD, Zaimis EJ.

Br J Pharmacol. 1997 Feb;120(4 Suppl):60-79; discussion 51-9. No abstract available.

3.

Aerosolised pentamidine.

Paton WD.

Lancet. 1987 Nov 14;2(8568):1146. No abstract available.

PMID:
2890038
4.

Effect of pressure on oxidative metabolism of drugs by mouse hepatic microsomes.

Marriage HJ, Paton WD, Harvey DJ.

Undersea Biomed Res. 1986 Sep;13(3):369-81.

PMID:
3022437
5.

Pharmacokinetics of delta 9-tetrahydrocannabinol in rabbits following single or multiple intravenous doses.

Leuschner JT, Harvey DJ, Bullingham RE, Paton WD.

Drug Metab Dispos. 1986 Mar-Apr;14(2):230-8.

PMID:
2870899
6.

On becoming and being a pharmacologist.

Paton WD.

Annu Rev Pharmacol Toxicol. 1986;26:1-22. No abstract available.

PMID:
3521451
7.

Species variation and the mechanism of pressure-anaesthetic interactions.

Smith EB, Bowser-Riley F, Daniels S, Dunbar IT, Harrison CB, Paton WD.

Nature. 1984 Sep 6-11;311(5981):56-7.

PMID:
6332278
8.

The partitioning of delta 1-tetrahydrocannabinol into erythrocyte membranes in vivo and its effect on membrane fluidity.

Leuschner JT, Wing DR, Harvey DJ, Brent GA, Dempsey CE, Watts A, Paton WD.

Experientia. 1984 Aug 15;40(8):866-8.

PMID:
6088277
9.

Changes in membrane lipid content after chronic ethanol administration with respect to fatty acyl compositions and phospholipid type.

Wing DR, Harvey DJ, Belcher SJ, Paton WD.

Biochem Pharmacol. 1984 May 15;33(10):1625-32.

PMID:
6732836
10.

How far do we understand the mechanism of anaesthesia?

Paton WD.

Eur J Anaesthesiol. 1984 Mar;1(1):93-103. No abstract available.

PMID:
6399254
11.

Animal experiment: British and European legislation and practice.

Paton WD.

Ann N Y Acad Sci. 1983;406:201-14. No abstract available.

PMID:
6576673
12.

Effects of chronic ethanol administration on the composition of membrane lipids in the mouse.

Wing DR, Harvey DJ, Hughes J, Dunbar PG, McPherson KA, Paton WD.

Biochem Pharmacol. 1982 Nov 1;31(21):3431-9.

PMID:
6890815
13.
14.

Hexamethonium.

Paton WD.

Br J Clin Pharmacol. 1982 Jan;13(1):7-14. No abstract available.

15.
17.
18.

Brain monoamines and the high pressure neurological syndrome.

Koblin DD, Little HJ, Green AR, Daniels S, Smith EB, Paton WD.

Neuropharmacology. 1980 Nov;19(11):1031-8. No abstract available.

PMID:
6449674
19.

Identification of the in vivo liver metabolites of (--)-delta 7-tetrahydrocannabinol produced by the mouse.

Harvey DJ, Gill EW, Slater M, Paton WD.

Drug Metab Dispos. 1980 Nov-Dec;8(6):439-45.

PMID:
6109613
20.

Identification of in vivo liver metabolites of delta 6-tetrahydrocannabinol produced by the mouse.

Harvey DJ, Paton WD.

Drug Metab Dispos. 1980 May-Jun;8(3):178-86.

PMID:
6104583
21.
22.

[14C]Serine incorporation into phospholipid in the guinea-pig ileum: effects of halothane [proceedings].

Wing DR, Paton WD.

Biochem Soc Trans. 1980 Feb;8(1):124-5. No abstract available.

PMID:
6768611
23.
25.

Ultrasonic imaging system for the study of decompression-induced gas bubbles.

Daniels S, Paton WD, Smith EB.

Undersea Biomed Res. 1979 Jun;6(2):197-207.

PMID:
531998
26.

The effects of some hydrophobic gases on the pulmonary surfactant system.

Daniels S, Paton WD, Smith EB.

Br J Pharmacol. 1979 Feb;65(2):229-35.

27.
28.

An effect of cannabis treatment in vivo on noradrenaline-stimulated lipolysis in rat adipocytes.

Wing DR, Paton WD.

J Pharm Pharmacol. 1978 Dec;30(12):802-3. No abstract available.

PMID:
32252
29.

Potency of mixtures of general anaesthetic agents.

Clarke RF, Daniels S, Harrison CB, Jordan MJ, Paton WD, Smith EB, Smith RA.

Br J Anaesth. 1978 Oct;50(10):979-83.

30.

Identification of six substituted 4''-hydroxy-metabolites of of delta1-tetrahydrocannabinol in mouse liver.

Harvey DJ, Paton WD.

Res Commun Chem Pathol Pharmacol. 1978 Sep;21(3):435-46.

PMID:
705022
31.
32.

Identification and measurement of cannabinoids and their in vivo metabolites in liver by gas chromatography--mass spectrometry.

Harvey DJ, Martin BR, Paton WD.

Adv Biosci. 1978 Jul 22-23;22-23:45-62. No abstract available.

PMID:
756842
33.
34.

In vivo metabolites of delta1(6)-tetrahydrocannabinol produced by the mouse via the epoxide-diol pathway.

Harvey DJ, Paton WD.

J Pharm Pharmacol. 1977 Aug;29(8):498-500. No abstract available.

PMID:
19601
35.

Identification of metabolites of delta1- and delta1(6)-tetrahydrocannabinol containing a reduced double bond.

Harvey DJ, Martin BR, Paton WD.

J Pharm Pharmacol. 1977 Aug;29(8):495-7. No abstract available.

PMID:
19600
36.
37.

Biotransformation of cannabidiol in mice. Identification of new acid metabolites.

Martin BR, Harvey DJ, Paton WD.

Drug Metab Dispos. 1977 May-Jun;5(3):259-67.

PMID:
17524
38.

Identification of glucuronides as in vivo liver conjugates of seven cannabinoids and some of their hydroxy and acid metabolites.

Harvey DJ, Martin BR, Paton WD.

Res Commun Chem Pathol Pharmacol. 1977 Feb;16(2):265-79.

PMID:
847285
39.
40.

Identification of the glucuronides of cannabidiol and hydroxycannabidiols in mouse liver.

Harvey DJ, Martin BR, Paton WD.

Biochem Pharmacol. 1976 Oct 1;25(19):2217-9. No abstract available.

PMID:
971336
41.

Identification of new in vivo side-chain acid metabolites of delta1-tetrahydrocannabinol.

Martin BR, Harvey DJ, Paton WD.

J Pharm Pharmacol. 1976 Oct;28(10):773-4. No abstract available.

PMID:
10374
42.

The anesthetic effect of oxygen.

Smith RA, Paton WD.

Anesth Analg. 1976 Sep-Oct;55(5):734-6.

PMID:
987735
43.

Pressure antagonism of anaesthetic-induced conduction failure in frog peripheral nerve.

Roth SH, Smith RA, Paton WD.

Br J Anaesth. 1976 Jul;48(7):621-8.

44.
45.

Sir Henry Dale (1875-1968), some letters and papers.

Paton WD.

Notes Queries. 1976 Jan;30(2):231-48. No abstract available.

PMID:
11609918
47.

The redistribution of vascular bubbles in multiple dives.

Gait D, Miller KW, Paton WD, Smith EB, Welch B.

Undersea Biomed Res. 1975 Mar;2(1):42-50. No abstract available.

PMID:
1181707
48.

The molecular basis of drug toxicity.

Paton WD.

J Clin Pathol Suppl (R Coll Pathol). 1975;9:1-6. No abstract available.

49.

Pharmacology of marijuana.

Paton WD.

Annu Rev Pharmacol. 1975;15:191-220. Review. No abstract available.

PMID:
807151
50.

Relative pharmacological potency in mice of optical isomers of delta 1-tetrahydrocannabinol.

Jones G, Pertwee RG, Gill EW, Paton WD, Nilsson IM, Widman M, Agurell S.

Biochem Pharmacol. 1974 Jan 15;23(2):439-46. No abstract available.

PMID:
4813356

Supplemental Content

Loading ...
Support Center